288. Autoimmune acquired coagulation factor deficiency Clinical trials / Disease details


Clinical trials : 206 Drugs : 231 - (DrugBank : 28) / Drug target genes : 10 - Drug target pathways : 21

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01800435
(ClinicalTrials.gov)
October 201115/2/2013A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With InhibitorWhole Blood Clot Stability and Thrombin Generating Capacity Following Treatment With Bypassing Agents (BPA) With and Without and Tranexamic Acid (TXA) in Haemophilia A Patients With inhibitor-an In-vivo Prospective Crossover StudyHereditary Factor VIII Deficiency Disease With InhibitorDrug: aPCC, aPCC + TXA;Drug: rFVIIa, rFVIIa + TXAOslo University HospitalNULLCompleted18 Years65 YearsMale6Phase 4Norway
2NCT00168077
(ClinicalTrials.gov)
September 200512/9/2005Prothrombin Complex Concentrate for Anticoagulant ReversalEfficacy and Tolerance of BERIPLEX® P/N in Subjects With Acquired Deficiency of Coagulation Factors II, VII, IX and X Due to Oral AnticoagulationAcquired Coagulation Factor DeficiencyDrug: Prothrombin Complex ConcentrateCSL BehringNULLCompleted18 YearsN/ABoth40Phase 3Austria;Germany;Hungary;Israel;Lithuania;Netherlands;Poland;Switzerland